The Intersect ENT 70011 Propel™ Implant is a bioabsorbable, steroid-releasing sinus implant designed to maintain sinus patency and reduce inflammation following frontal and maxillary sinus surgery. Containing mometasone furoate, a trusted corticosteroid, it delivers controlled, localized anti-inflammatory therapy directly to the sinus tissue, significantly reducing the need for postoperative interventions such as debridement and adhesiolysis.